Joint Juice Dietary Supplements
Between November 2016 and January 2017, multiple class action lawsuits were filed against Joint Juice for allegedly deceptively marketing its line of glucosamine supplements. Specifically, the complaints allege that the supplements will support and nourish cartilage, lubricate joints, and improve joint comfort when, in reality, scientific studies conclude that the ingredients in the products do not provide the advertised benefits.
To learn more and read the complaints, click on the case information below.
- Dent et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6721, N. D. CA.
- Fishon et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6980, N. D. CA.
- Lux et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6703, N. D. CA.
- Ravinsky et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6704, N. D. CA.
- Sandoval et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6708, N. D. CA.
- Schupp et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 17-cv-54, N. D. CA.
- Simmons et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-7078, N. D. CA.
- Spencer et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-7097, N. D. CA.
- Taylor et al v. Premier Nutrition Corporation f/k/a/ Joint Juice, Inc., Case No. 16-cv-7097, N. D. CA.
For more information about other class-action lawsuits regarding glucosamine products and TINA.org’s coverage of the products, click here.
Class-Action Tracker
The Latest
Garden & Gather’s ‘100% Money Back Guarantee’ and ‘Free Returns’
Consumers’ attempts to obtain a full refund may only yield a meager harvest.
New York City is Taking on Shady Subscriptions
And TINA.org is all for it.
What You Should Know about Kalshi
Prediction market faces legal challenges on multiple fronts.
NJ tax dollars spent on ‘Blue Ribbon’ school awards that critics call deceptive
Julie O’Connor, NJ Spotlight News
The Regulatory Loopholes Behind Prevagen’s Rise
Sara Talpos, Med Shadow